Skip to content

90%-effective Dose (ED90) of Remimazolam Toislate in Combination with Remifentanil in Painless Induced Abortion.

90%-effective Dose (ED90) of Remimazolam Toislate in Combination with Remifentanil in Painless Induced Abortion.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076360
Enrollment
Unknown
Registered
2023-10-07
Start date
2023-10-10
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless induced abortion

Interventions

Remimazolam group:Intravenous remimazolam toislate injection was given intraoperatively

Sponsors

Haining People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Patients planning to undergo abortion surgery under intravenous anesthesia (excluding patients undergoing curettage after incomplete abortion); 2. Age 18~45 years; 3. ASA Class I or II. 4.BMI 18~30.0 kg/m2; 5.Patients who have no communication barriers and agree and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. The surgery is expected to be complex or requires special procedures (surgery time>=30 minutes); 2.Patients with difficult airways; 3.History of hypertension (SBP>180mmHg or DBP>110mmHg); 4.Hepatorenal insufficiency; 5.Chronic lung disease with air intake SPO2<95%; 6.Long term use of analgesics/psychotropic drugs, previous history of drug use, and long-term history of alcohol abuse; 7.Patients who received sedative medication 24 hours before surgery; 8.Patients who are allergic to benzodiazepines, opioids, and NSAIDS.

Design outcomes

Primary

MeasureTime frame
Body movement reaction;

Secondary

MeasureTime frame
Hypotension;Hypoxemia;Nausea and vomiting;Respiratory depression;Dizzy;Cough;Injection pain;

Countries

China

Contacts

Public ContactBing Yan

Haining People's Hospital

hnphyb@163.com+86 138 1972 5594

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026